Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection.
Zai W, Yang M, Jiang K, Guan J, Wang H, Hu K, Huang C, Chen J, Fu W, Zhan C, Yuan Z.
Signal Transduct Target Ther. 2024 Jun 21;9(1):150. doi: 10.1038/s41392-024-01871-8.
OSHA Bloodborne Pathogen Standards.
Denault D, Gardner H.
2023 Jul 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance.
Meng CY, Sun S, Liang Y, Xu H, Zhang C, Zhang M, Wang FS, Fu YX, Peng H.
Gut. 2023 Aug;72(8):1544-1554. doi: 10.1136/gutjnl-2022-327059. Epub 2022 Oct 31.
Novel delivery methods for treatment of viral hepatitis: an update.
Virovic L, Wu CH, Konishi M, Wu GY.
Expert Opin Drug Deliv. 2005 Jul;2(4):707-17. doi: 10.1517/17425247.2.4.707.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R…
Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 Feb 8.
Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment.
Dusheiko GM.
Br Med Bull. 1990 Apr;46(2):492-511. doi: 10.1093/oxfordjournals.bmb.a072412.
Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.
Shen Z, Zhang S, Jiang Q, Liu N, Li F, Gao Z, Pan S, Hao W, Deng Q, Liu J, Zhang J, Xie Y.
J Med Virol. 2023 Sep;95(9):e29062. doi: 10.1002/jmv.29062.
The effect of intrahepatic cholestasis in pregnancy combined with different stages of hepatitis B virus infection on pregnancy outcomes: a retrospective study.
Gao Q, Li X, Wang L, Tan X, Li Z, Xu C.
BMC Pregnancy Childbirth. 2024 Apr 6;24(1):245. doi: 10.1186/s12884-024-06460-9.
Molecular therapeutics of HBV.
Xu R, Cai K, Zheng D, Ma H, Xu S, Fan ST.
Curr Gene Ther. 2003 Aug;3(4):341-55. doi: 10.2174/1566523034578294.
New therapies for chronic hepatitis B.
Bitton Alaluf M, Shlomai A.
Liver Int. 2016 Jun;36(6):775-82. doi: 10.1111/liv.13086. Epub 2016 Mar 14.
